Holen Sie sich die Stockscreener-App
55.17
0.33%
0.34
Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten
Soleno Therapeutics Reports Q3 Progress and Financials - TipRanks
PERCEPTIVE ADVISORS LLC Reduces Stake in Soleno Therapeutics Inc - GuruFocus.com
Perceptive Advisors LLC Increases Stake in Soleno Therapeutics I - GuruFocus.com
Objective long/short (SLNO) Report - Stock Traders Daily
Soleno Therapeutics Announces Oral Presentations featuring - GlobeNewswire
Avoro Capital Advisors LLC Increases Stake in Soleno Therapeutics Inc - GuruFocus.com
Soleno Therapeutics' SWOT analysis: rare disease stock poised for FDA decision - Investing.com Australia
Here's Why We're Not At All Concerned With Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation - Yahoo Finance
HC Wainwright Reiterates Buy Rating for Soleno Therapeutics (NASDAQ:SLNO) - MarketBeat
Companies Like Soleno Therapeutics (NASDAQ:SLNO) Can Afford To Invest In Growth - Simply Wall St
Harbor Capital Advisors Inc. Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - MarketBeat
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - The Manila Times
Soleno Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Capnia Inc stock soars to 52-week high, hits $58 mark - Investing.com
(SLNO) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Brokerages Set Soleno Therapeutics, Inc. (NASDAQ:SLNO) Target Price at $69.86 - Defense World
Emerald Advisers LLC Grows Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $73.00 at Oppenheimer - Defense World
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) Hits New 52-Week High Following Analyst Upgrade - Defense World
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Stake Boosted by Allspring Global Investments Holdings LLC - Defense World
Capnia Inc stock soars to 52-week high of $56.89 amid robust growth By Investing.com - Investing.com South Africa
Soleno Therapeutics shares remain Outperform as analyst lifts price target on updated sales projections - Investing.com Australia
Soleno Therapeutics (NASDAQ:SLNO) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat
Capnia Inc stock soars to 52-week high of $56.89 amid robust growth - Investing.com India
Oppenheimer Boosts Soleno Therapeutics (NASDAQ:SLNO) Price Target to $73.00 - MarketBeat
Soleno Therapeutics to Participate in Upcoming November Investor Conferences - GlobeNewswire
(SLNO) Technical Data - Stock Traders Daily
Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D. - GlobeNewswire
TriMas, Soleno Therapeutics, Ring Energy, and More Stocks See Action From Activist Investors - Barron's
SLNO Stock Rises on Upbeat Regulatory Update on PWS Drug NDA - MSN
Prader-Willi Syndrome Market to Drive Growth with Prominent - openPR
Soleno Therapeutics (SLNO): Pioneering Treatment for Prader-Willi Syndrome with DCCR - Insider Monkey
Soleno Therapeutics Inc (SLNO)’s stock price in review: A technical analysis - US Post News
Soleno Therapeutics (SLNO): Breakthroughs in Prader-Willi Syndrome Treatment - Insider Monkey
The Potential Rise in the Price of Soleno Therapeutics Inc (SLNO) following insiders activity - Knox Daily
Soleno Therapeutics (NASDAQ:SLNO) Trading Up 6.4%Time to Buy? - MarketBeat
Insider’s View: Deciphering Soleno Therapeutics Inc (SLNO)’s Financial Health Through Ratios - The Dwinnex
Carlyle Group Inc.'s Strategic Reduction in Soleno Therapeutics Inc. - GuruFocus.com
Taking a look at what insiders are doing to gauge the Soleno Therapeutics Inc (SLNO)’s direction - Knox Daily
Soleno Therapeutics Nears FDA Decision: Strong Buy Targeting PWS Hyperphagia Treatments - Seeking Alpha
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Holdings Lifted by The Manufacturers Life Insurance Company - MarketBeat
Soleno Therapeutics Inc [SLNO] Revenue clocked in at $0.00 million, up 29.12% YTD: What’s Next? - The DBT News
Recent Price Trend in Soleno Therapeutics (SLNO) is Your Friend, Here's Why - Yahoo Canada Finance
Belite Delights Investors, Soleno, ADMA, Harrow Deliver Triple-digit Gains, Keep An Eye On Oculis - RTTNews
FDA leans away from advisory meeting for Soleno's PWS drug By Investing.com - Investing.com South Africa
Laidlaw maintains buy rating, $75 target on Soleno Therapeutics By Investing.com - Investing.com Australia
Soleno shares set to surge on positive FDA update - Investing.com India
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):